CLINICAL ROLE -
Alzheimer's Disease Treatment Reduces Inflammation Related to Metabolic Syndrome
Galantamine observed to reduce pro-inflammatory markers in patients with metabolic syndrome.
Read More
FDA Panel Does Not Recommend Abuse-Deterrent Version of OxyContin for Approval
An FDA panel voted against recommending Intellipharmaceutics’ Rexista abuse-deterrent oxycodone hydrochloride extended release tablets, according to a company press release.
Socialization With Cancer Survivors May Impact Patient Response to Chemotherapy
Interaction between patients with cancer during chemotherapy may increase 5-year survival.
Weight Gain During Adulthood Increases Risk of Diabetes, Cancer
Gaining more than 5 pounds linked to several chronic diseases and overall poor health.
Trending News Today: More Than 250 Contaminants Found in US Water Supplies Pose Health Risks
Top news of the day from across the health care landscape.
World Hepatitis Day Continues Push to Eradicate Virus Across the Globe
World Hepatitis Day highlights awareness and prevention initiatives in effort to improve access to curative treatments.
Global Fight Against Hepatitis Continues with World Hepatitis Day
World Hepatitis Day brings awareness to the burden of hepatitis, which is a leading cause of death worldwide.
Trending News Today: Skinny Repeal May Destabilize Insurance Market Further
Top news of the day from across the healthcare landscape.
USPSTF Advises Against Routine Ovarian Cancer Screening
US Preventive Services Task Force states that screening tests for ovarian cancer are often inaccurate.
Role of 5-HT3 Receptor Antagonists in Treating CINV
Watch
Treating CINV Due to Immunotherapy and Targeted Therapy
Patient Education Materials for CINV
Patient Risk Factors in CINV
Classification of Emetogenicity of Chemotherapeutic Agents
Types of CINV
Multidisciplinary Approach to Treating CINV
Challenges in the Treatment of CINV
4 Poison Ivy, Oak, and Sumac Counseling Points
Many individuals develop a rash from poison ivy, oak, or sumac from the oil found in the sap of these poisonous plants.
NCPA Rebuts Misleading PBM Research Paper On DIR Fees
Research into Type 1 Diabetes Vaccine Takes Leap Forward
Inhibiting beta cell infection from enteroviruses may prevent the development of type 1 diabetes.
Medicare Part B Improvement Act Passes House
Legislation expands access to home infusion services for Medicare beneficiaries.
New Generic Drugs Emerge for Migraines, Cardiovascular Conditions
Six new generic drugs for various cardiovascular-related conditions, brain cancer, and migraines expected to result in significant savings.
Rhode Island Pharmacists Take Steps Towards Provider Status
Pharmacists offer prophylactic Lyme Disease antibiotics without physician visit.
HIV Suppression Maintained After Switch to Dolutegravir Regimen
Dolutegravir-based treatment non-inferior to boosted protease inhibitor regimen in virally suppressed HIV-positive patients.
Neoadjuvant Therapy Reduces Risk of Secondary Primary Cancer in Early-Stage Breast Cancer
Investigators compare long-term overall and disease-free survival rates in neoadjuvant versus adjuvant radiotherapy.
Trending News Today: Latest Version of ACA Replacement Bill Rejected in Senate
Cancer Research Reveals Pathway to Attack Drug-Resistant Superbugs
New class of antibiotics targets the mitochondria of superbugs, such as MRSA.
HER2-Positive Breast Cancer Market to Increase Substantially
Global market for HER2-positive breast cancer to increase to $9.89 billion in 2025.
Progress Made Towards Treatment for Neimann-Pick Disease
Investigational treatment may reduce lipid build-up in patients with Neimann-Pick type C1.
Let's Talk: Medication Adherence
In an evolving and technology-driven world, mobile text messaging is a feasible electronic option to improve adherence, as more people from all socioeconomic classes and age groups are using this technology
